Sterling Capital Management LLC Adma Biologics, Inc. Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 228 shares of ADMA stock, worth $3,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
228
Previous 229
0.44%
Holding current value
$3,625
Previous $4.58 Million
14.59%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
337Shares Held
183MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$296 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$289 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$180 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$88 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.12B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...